Foundations of Preclinical Drug Safety Assessment

Ensuring patient safety is the most critical hurdle in the journey of any new medicine from the laboratory to the pharmacy. This course introduces the rigorous scientific processes used to identify potential hazards and establish safe boundaries for new drug candidates before they ever reach a human volunteer. You will gain a clear understanding of how the industry evaluates promising molecules to minimize risk and maximize therapeutic potential. By completing this course, you will be able to interpret the data derived from safety studies and understand the scientific reasoning that informs early-stage drug development decisions. You will learn how to translate complex biological signals into actionable safety profiles. What you'll learn: - Define foundational concepts in pharmacology, toxicology, and regulatory safety requirements - Analyze in vitro and in vivo methodologies used to detect early safety signals - Calculate the therapeutic index and establish safety margins for clinical use - Review modern approaches including in silico modeling and microphysiological systems - Interpret safety data to inform first-in-human dose selection - Practice risk assessment through written scenarios and structured safety evaluations This text-based course begins with essential terminology and the historical context of drug safety before moving into specific toxicological methodologies and data-driven risk assessment. You will progress from basic biological concepts to the practical application of safety data in a professional drug development environment. This course is designed for beginners in the pharmaceutical and biotech industries, life sciences students, or professionals transitioning into drug development roles. No prior experience in toxicology or clinical research is required. Begin building your expertise in preclinical safety today.